Title: Global Biodefense Market size forecast to exceed $17bn by 2024
1Global Biodefense Market size worth 17bn by
2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2 Key Insights from Biodefense Market
- Global biodefense market size was driven by the
anthrax segment, which was USD 3 billion in 2015
and is anticipated to grow at 5 from 2016 to
2024. - Revenue growth will be propelled by smallpox
segment that is set to increase at 7.4 CAGR
estimations to exceed USD 4 billion by 2024. - Eminent companies entered into contracts with the
government for addressing a range of healthcare,
scientific, national security and international
security issues, which has led to high U.S.
biodefense market share. -
3Continued...
- European countries of Germany and UK are set to
witness lucrative growth rate due to designated
funding policies in place. - Companies operating in the industry include Xoma
Corporation, Emergent Biosolutions, Cleveland
BioLabs, Nanotherapeutics, SIGA Technologies,
etc. Presence of extensive product portfolio and
strong pipeline will contribute to profitability.
4U.S. Biodefense Market Size, by Product, 2012 -
2024 (USD Million)
5 Browse Full Market Research Report On
Biodefense Market _at_ http//goo.gl/StkvoL
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/714 https//www.gminsights.com/request-sample/de
tail/49
6360 Analysis
- Product Analysis
- Anthrax contributed 31.5 to the overall
biodefense market share in 2015, with target size
slated to exceed USD 4.2 billion by 2023.
Bacillus anthracis is recognized to be of
highest priority in biodefense research, and
placed among the nine agents in class A as per
the classification by CDC. This was followed by
smallpox, which is now eradicated worldwide
following the global immunization process. - Regional Analysis
- North America contributed the largest regional
share, with USD 8.9 billion in 2015. U.S.
biodefense market share dominated North American
revenue, which can be attributed to the
increasing government initiatives, funding for
biodefense, and implementation of Project
BioShield in 2004 with an objective of research
fund allocation across the federal agencies. - Competitive Market Share
- The major players include Xoma Corporation,
Emergent Biosolutions, PharmaAthene,
Bavarian-Nordic, SIGA Technologies, and Cleveland
BioLabs, etc.
7 Stay In Touch Website www.gminsights.com Soci
al Media